NEW YORK MiMedx Group Inc finalized a deal Sunday to acquire Stability Biologics for $10 million in cash and stock.
The regenerative medicine company MiMedx said the acquisition of Stability Biologics, a provider of human tissue and bone graft products, adds a new sales channel and roughly 100 salespeople to the company.
17:35 Boeing to open first European factory, to invest 20 million pounds21
20:13 Own Amazon Stock? Here's What You Need to Know About FedEx and UPS Earnings24
07:15 Telefonica to sell up to 40 percent of Telxius to KKR for 1.3 billion euros22
19:57 Kraft withdraws offer to merge with Unilever31